Réactifs et instruments pour l'immunologie, la biologie cellulaire et la biologie moléculaire.
 
> Myrcene [123-35-3]

Myrcene [123-35-3]

Imprimer Imprimer
Identifiez-vous
Commande minimum 2

Référence HY-N0803-1g

Conditionnement : 1g

Marque : MedChemExpress

Demander plus d'informations

Contactez votre distributeur local :


Téléphone : +1 850 650 7790

Myrcene (β-Myrcene) is a type of aromatic compound that inhibits TNFα and NF-κB activity. Myrcene has anti-invasive action, inhibits cell cycle, and leads to cancer cell apoptosis. Myrcene has strong blood protection effect, anti-inflammation, and anti-inflammatory activity.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

Myrcene Chemical Structure

Myrcene Chemical Structure

CAS No. : 123-35-3

This product is a controlled substance and not for sale in your territory.

Based on 1 publication(s) in Google Scholar

Other Forms of Myrcene:

  • Myrcene-d6 Obtenir un devis
  • Myrcene-13C3 Obtenir un devis
  • Myrcene (Standard) Obtenir un devis

Voir tous les produits spécifiques à Isoform NF-κB:

Voir toutes les isoformes
NF-κB NF-κB1/p50 RelA/p65 RelB c-Rel
Description

Myrcene (β-Myrcene) is a type of aromatic compound that inhibits TNFα and NF-κB activity. Myrcene has anti-invasive action, inhibits cell cycle, and leads to cancer cell apoptosis. Myrcene has strong blood protection effect, anti-inflammation, and anti-inflammatory activity[1][2][3][4][5].

IC50 & Target[1][2]

NF-κB

 

In Vitro

Myrcene (50 μM, 100 μM; 24 h, 48 h) inhibits 10 ng/mL TNFα-induced NF-κB activity, through causing the inactivation of IKK in MDA-MB-231 cells[2].
Myrcene (0.25-1.0 μg/mL; 24 h, 48 h) inhibits clonal sphere formation in A549 cells, and arrests cell cycle in the G0/G1 phases to cause apoptosis[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Myrcene Related Antibodies
In Vivo

Myrcene (100 mg/kg, 200 mg/kg; ip; 30 days) can improve the effects of AlCl3 (5 mg/kg; p. o.) and D-galactose (60 mg/kg; i. p.) in mice. Alleviates neurobehavioral and neuropathological effect[4].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Essai clinique
Masse moléculaire

136.23

Formule

C10H16
CAS No.

123-35-3
Appearance

Liquid (Density: 0.791 g/cm3)

Color

Colorless to light yellow

SMILES

C=CC(CC/C=C(C)/C)=C
Structure Classification
  • Terpenoids
  • Other Monoterpenes
Initial Source
  • Plants
  • Pinaceae
  • Pinus sylvestris Linn. var. mongolica Litv.
  • Microorganisms
Livraison

Room temperature in continental US; may vary elsewhere.
Stockage

-20°C, stored under nitrogen

*In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)

Solvant et solubilité
In Vitro: 

Ethanol : ≥ 100 mg/mL (734.05 mM)

DMSO : 100 mg/mL (734.05 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

*"≥" means soluble, but saturation unknown.

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 7.3405 mL 36.7026 mL 73.4053 mL
5 mM 1.4681 mL 7.3405 mL 14.6811 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Calculateur de molarité

  • Calculateur de dilution

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

  • Protocol 1

    Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

    Solubility: ≥ 2.5 mg/mL (18.35 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

    Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
  • Protocol 2

    Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

    Solubility: ≥ 2.5 mg/mL (18.35 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

    Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
%
DMSO +
% 
+
%
Tween-80 +
%
Saline
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Calculation results:
Working solution concentration: mg/mL
Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).

*In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
 If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Pureté et documentation

Purity: ≥75.0%

COA (240 KB) HNMR (239 KB)

Instruction de manipulation (2659 KB)
Références

  • [1]. Eunson Hwang, et al. Myrcene, an Aromatic Volatile Compound, Ameliorates Human Skin Extrinsic Aging via Regulation of MMPs Production. Am J Chin Med. 2017;45(5):1113-1124.  [Content Brief]

    [2]. Jeong-Ho Lee, et al. Anti-invasive effect of β-myrcene, a component of the essential oil from Pinus koraiensis cones, in metastatic MDA-MB-231 human breast cancer cells. Journal of the Korean Society for Applied Biological Chemistry volume 58, pages563–569.

    [3]. Bai X, et al. Myrcene exhibits antitumor activity against lung cancer cells by inducing oxidative stress and apoptosis mechanisms[J]. Natural Product Communications, 2020, 15(9): 1934578X20961189.

    [4]. Islam AUS, et al. Myrcene Attenuates Renal Inflammation and Oxidative Stress in the Adrenalectomized Rat Model. Molecules. 2020 Sep 30;25(19):4492.  [Content Brief]

    [5]. Kumar R, et al. Ameliorative effect of myrcene in mouse model of Alzheimer's disease. Eur J Pharmacol. 2021 Nov 15;911:174529.  [Content Brief]

  • [1]. Eunson Hwang, et al. Myrcene, an Aromatic Volatile Compound, Ameliorates Human Skin Extrinsic Aging via Regulation of MMPs Production. Am J Chin Med. 2017;45(5):1113-1124.

    [2]. Jeong-Ho Lee, et al. Anti-invasive effect of β-myrcene, a component of the essential oil from Pinus koraiensis cones, in metastatic MDA-MB-231 human breast cancer cells. Journal of the Korean Society for Applied Biological Chemistry volume 58, pages563–569.

    [3]. Bai X, et al. Myrcene exhibits antitumor activity against lung cancer cells by inducing oxidative stress and apoptosis mechanisms[J]. Natural Product Communications, 2020, 15(9): 1934578X20961189.

    [4]. Islam AUS, et al. Myrcene Attenuates Renal Inflammation and Oxidative Stress in the Adrenalectomized Rat Model. Molecules. 2020 Sep 30;25(19):4492.

    [5]. Kumar R, et al. Ameliorative effect of myrcene in mouse model of Alzheimer's disease. Eur J Pharmacol. 2021 Nov 15;911:174529.

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
Ethanol / DMSO 1 mM 7.3405 mL 36.7026 mL 73.4053 mL 183.5132 mL
5 mM 1.4681 mL 7.3405 mL 14.6811 mL 36.7026 mL
10 mM 0.7341 mL 3.6703 mL 7.3405 mL 18.3513 mL
15 mM 0.4894 mL 2.4468 mL 4.8937 mL 12.2342 mL
20 mM 0.3670 mL 1.8351 mL 3.6703 mL 9.1757 mL
25 mM 0.2936 mL 1.4681 mL 2.9362 mL 7.3405 mL
30 mM 0.2447 mL 1.2234 mL 2.4468 mL 6.1171 mL
40 mM 0.1835 mL 0.9176 mL 1.8351 mL 4.5878 mL
50 mM 0.1468 mL 0.7341 mL 1.4681 mL 3.6703 mL
60 mM 0.1223 mL 0.6117 mL 1.2234 mL 3.0586 mL
80 mM 0.0918 mL 0.4588 mL 0.9176 mL 2.2939 mL
100 mM 0.0734 mL 0.3670 mL 0.7341 mL 1.8351 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Myrcene Related Classifications

  • Others
  • NF-κB
  • NF-κB
Help & FAQs

Keywords:

Myrcene123-35-3β-MyrceneNF-κBNuclear factor-κBNuclear factor-kappaBaromatic volatileTNFαanti-invasive effectInhibitorinhibitorinhibit